Monkeypox: WHO to convene second meeting to decide on declaring global health emergency   

GENEVA: The World Health Organization will reconvene its expert monkeypox committee on Thursday to decide whether the outbreak now constitutes a global health emergency -- the highest alarm it can sound.

A second meeting of the WHO's emergency committee on the virus will be held to examine the evidence of the worsening situation, with nearly 14,000 cases reported from more than 70 countries.

A surge in monkeypox infections has been reported since early May outside the West and Central African countries where the disease has long been endemic.

On June 23, the WHO convened an emergency committee of experts to decide if monkeypox constitutes a so-called Public Health Emergency of International Concern (PHEIC) -- the UN health agency's highest alert level.

But a majority advised the WHO's chief Tedros Adhanom Ghebreyesus that the situation, at that point, had not met the threshold.

Now a second meeting will be held, with case numbers rising and spreading to six more countries in the past week.

If the committee advises Tedros that the outbreak constitutes a PHEIC, it will propose temporary recommendations on how to better prevent and reduce the spread of the disease and manage the global public health response.

But there is no timetable for when the outcome will be made public.

Information battle

Ninety-eight per cent of reported cases "are among men who have sex with men (MSM) -- and primarily those who have multiple recent anonymous or new partners," Rosamund Lewis, the WHO's technical lead for monkeypox, told a press conference on Wednesday.

They are typical of young age and chiefly in urban areas, according to the WHO.

The committee will look at the latest trends and data, how effective the countermeasures are and make recommendations for what countries and communities should do to tackle the outbreak.

Regardless of the committee's PHEIC decision, the "WHO will continue to do everything we can to support countries to stop transmission and save lives," Tedros told the press conference.

He said the WHO was validating, procuring and shipping tests to multiple countries, but said one of the most powerful tools in the fight against monkeypox was information.

"That's why WHO is continuing to work with patients and community advocates to develop and deliver information tailored to the affected communities," Tedros said.

WHO emergencies director Michael Ryan said the LGBTQ community was one of the most engaged and responsible, having worked hard over decades to combat HIV, "so, therefore, we have full confidence that this community can, and will, and is, engaging very closely".

A viral infection resembling smallpox and first detected in humans in 1970, monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980.

 'Scary and exhausting' 

The European Centre for Disease Prevention and Control said that as of Monday, 7,896 confirmed cases had been reported from 27 countries in the European Economic Area.

The worst affected were Spain (2,835), Germany (1,924), France (912), the Netherlands (656) and Portugal (515).

"Particular sexual practices are very likely to have facilitated and could further facilitate the transmission of monkeypox among MSM groups," it said.

Danish company Bavarian Nordic is the lone laboratory manufacturing a licensed vaccine against monkeypox and jabs are currently in scarce supply.

New York, the epicentre of the US outbreak with more than 460 cases, had either administered or scheduled 21,500 vaccines by Sunday, with long lines of men aged 20 to 40 queueing to get a shot.

Loyce Pace, the US assistant secretary of state for global public affairs, said it was "very hard" for the world to handle monkeypox on top of Covid-19 and other health crises.

"I know it can be scary... and, frankly, exhausting," she told reporters at the US mission in Geneva.

However, "we know a lot more about this disease, we've been able to stop outbreaks previously and we, importantly, have medical counter-measures and other tools available."

GENEVA: The World Health Organization will reconvene its expert monkeypox committee on Thursday to decide whether the outbreak now constitutes a global health emergency -- the highest alarm it can sound. A second meeting of the WHO's emergency committee on the virus will be held to examine the evidence of the worsening situation, with nearly 14,000 cases reported from more than 70 countries. A surge in monkeypox infections has been reported since early May outside the West and Central African countries where the disease has long been endemic. On June 23, the WHO convened an emergency committee of experts to decide if monkeypox constitutes a so-called Public Health Emergency of International Concern (PHEIC) -- the UN health agency's highest alert level. But a majority advised the WHO's chief Tedros Adhanom Ghebreyesus that the situation, at that point, had not met the threshold. Now a second meeting will be held, with case numbers rising and spreading to six more countries in the past week. If the committee advises Tedros that the outbreak constitutes a PHEIC, it will propose temporary recommendations on how to better prevent and reduce the spread of the disease and manage the global public health response. But there is no timetable for when the outcome will be made public. ALSO READ | Protocol for handling monkeypox cases released in Kerala Information battle Ninety-eight per cent of reported cases "are among men who have sex with men (MSM) -- and primarily those who have multiple recent anonymous or new partners," Rosamund Lewis, the WHO's technical lead for monkeypox, told a press conference on Wednesday. They are typical of young age and chiefly in urban areas, according to the WHO. The committee will look at the latest trends and data, how effective the countermeasures are and make recommendations for what countries and communities should do to tackle the outbreak. Regardless of the committee's PHEIC decision, the "WHO will continue to do everything we can to support countries to stop transmission and save lives," Tedros told the press conference. He said the WHO was validating, procuring and shipping tests to multiple countries, but said one of the most powerful tools in the fight against monkeypox was information. "That's why WHO is continuing to work with patients and community advocates to develop and deliver information tailored to the affected communities," Tedros said. WHO emergencies director Michael Ryan said the LGBTQ community was one of the most engaged and responsible, having worked hard over decades to combat HIV, "so, therefore, we have full confidence that this community can, and will, and is, engaging very closely". A viral infection resembling smallpox and first detected in humans in 1970, monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980. ALSO READ | Mangaluru: 30 co-passengers of second monkeypox patient home isolated  'Scary and exhausting'  The European Centre for Disease Prevention and Control said that as of Monday, 7,896 confirmed cases had been reported from 27 countries in the European Economic Area. The worst affected were Spain (2,835), Germany (1,924), France (912), the Netherlands (656) and Portugal (515). "Particular sexual practices are very likely to have facilitated and could further facilitate the transmission of monkeypox among MSM groups," it said. Danish company Bavarian Nordic is the lone laboratory manufacturing a licensed vaccine against monkeypox and jabs are currently in scarce supply. New York, the epicentre of the US outbreak with more than 460 cases, had either administered or scheduled 21,500 vaccines by Sunday, with long lines of men aged 20 to 40 queueing to get a shot. Loyce Pace, the US assistant secretary of state for global public affairs, said it was "very hard" for the world to handle monkeypox on top of Covid-19 and other health crises. "I know it can be scary... and, frankly, exhausting," she told reporters at the US mission in Geneva. However, "we know a lot more about this disease, we've been able to stop outbreaks previously and we, importantly, have medical counter-measures and other tools available."